ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

NCAB Says Restrictions on Animal Research Threatens Progress

May 20, 1988

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974